Chinese Biotech Firm Realbio Raises Nearly $15M Series A+ Round

Login to View

Chinese biotechnology firm Realbio Technology has raised nearly RMB100 million (US$14.93 million) in a series A round of financing led by Chinese venture capital firm Shandong Luxin High-Tech Industry, according to a statement released on Wednesday.

China Money Network

Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access Over 11,000 stories and data posts over the past 8 years!

Register Now

Already have an account or paid subscription? Log in

China Money Network Subscription